AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2021
Dec 17, 2021
34097_dirs_2021-12-16_048aa4a6-5902-497b-bd86-0c157d9cf0ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Skye Bioscience, Inc. (SKYE)
CIK: 0001516551
Period of Report: 2021-12-14
Reporting Person: Ward Keith Wayne (Director)
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10